Skip to content

Daclatasvir Impurity 1

Daclatasvir Impurity 1

Product Description
CAT No.
ALN-D036023
CAS No.
24860-53-5
Mol. F.
C16H12Cl2O2
Mol. Wt.
307.2
Stock
Please Inquire
RFQ
Chemical Name : 1,1′-([1,1′-Biphenyl]-4,4′-diyl)bis(2-chloroethan-1-one)
Smiles : ClCC(C1=CC=C(C2=CC=C(C(CCl)=O)C=C2)C=C1)=O
Inchi : InChI=1/C8H15NO2.ClH/c10-6-8(11)5-9-3-1-7(8)2-4-9;/h7,10-11H,1-6H2;1H

A validated stability-indicating reverse-phase high-performance liquid chromatography method for daclatasvir, identification and characterization of degradation products using LC-ESI-QTOF-MS

By Warghade, Snehal V.; Bothara, Kailash G.nFrom Asian Journal of Pharmaceutical and Clinical Research (2019), 12(5), 302-308

Development and validation of HPLC fluorescence and UPLC/DAD stability-indicating methods for determination of hepatitis C antiviral agent daclatasvir

By Kamal, Andra H.; Ismail, Nahla S.; Mabroijk, Mokhtar M.; Bebawy, Lories I.; Mekky, Mai A. – From Journal of AOAC International (2019), 102(4), 1125-1131

A stability-indicating UPLC method for the determination of potential impurities and its mass by a new QDa mass detector in daclatasvir drug used to treat hepatitis C infection

By Jagadabi, Varaprasad; Kumar, P. V. Nagendra; Mahesh, Kasthuri; Pamidi, Srinivasu; Ramaprasad, L. A.; Nagaraju, D. – From Journal of Chromatographic Science (2019), 57(1), 44-53

Request For Quotation

Related Products